SARS

Active Research Protocols

  1. 08-I-0093 – A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
  2. 10-I-0197 – Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014